Year: 2022
Type: editorial
Abstract: ADVERTISEMENT RETURN TO ISSUEEditorialNEXTThe Myth of Meritocracy in the Pharmaceutical SciencesLynne S. TaylorLynne S. TaylorMore by Lynne S. Taylorhttps://orcid.org/0000-0002-4568-6021Cite this: Mol. Pharmaceutics 2022, 19, 3, 729–730Publication Date (Web):March 7, 2022Publication History Published online7 March 2022Published inissue 7 March 2022https://pubs.acs.org/doi/10.1021/acs.molpharmaceut.2c00118https://doi.org/10.1021/acs.molpharmaceut.2c00118editorialACS PublicationsCopyright © 2022 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views2272Altmetric-Citations1LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (540 KB) Get e-Alertsclose Get e-Alerts
Source: Molecular Pharmaceutics
Author: Lynne S. Taylor
Language: English
Subfield: Information Systems and Management
Field: Decision Sciences
Domain: Social Sciences
Open Access status: bronze
OpenAlex ID: W4221010263